Cargando…

Corticosteroids: A Controversial Therapy for Coronavirus Disease 2019

Detalles Bibliográficos
Autores principales:	She, Jun, Hou, Dongni, He, Hong, Song, Yuanlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534500/ https://www.ncbi.nlm.nih.gov/pubmed/33062586 http://dx.doi.org/10.2478/jtim-2020-0019

Ejemplares similares

Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis
por: Wu, Chaomin, et al.
Publicado: (2020)

Effectiveness and Controversy of Convalescent Plasma Therapy for Coronavirus Disease 2019 Patients
por: Shu, Zhanjun, et al.
Publicado: (2021)

Asthma, biologics, corticosteroids, and coronavirus disease 2019
por: Akenroye, Ayobami T., et al.
Publicado: (2020)

Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism
por: Song, Yijun, et al.
Publicado: (2023)

Coronavirus disease 2019 and its controversial results during pregnancy
por: Volpato, Fernanda, et al.
Publicado: (2021)

Challenges of vaccination and herd immunity in COVID‐19 and management strategies
por: She, Jun, et al.
Publicado: (2022)

2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies
por: She, Jun, et al.
Publicado: (2020)

Corticosteroids/immunosuppressants: Coronavirus disease 2019: case report
Publicado: (2020)

Dexamethasone: a corticosteroid drug for the treatment of coronavirus disease 2019
por: Riaz, Muhammad, et al.
Publicado: (2022)

Feasibility of coronavirus disease 2019 eradication
por: Zheng, Ya-Li, et al.
Publicado: (2020)

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019
por: Bansal, Pankaj, et al.
Publicado: (2020)

Corticosteroids Utilization in the Management of Critically Ill Coronavirus Disease-2019 Pneumonia
por: Yang, Cheng, et al.
Publicado: (2022)

Intranasal Corticosteroids Are Associated with Better Outcomes in Coronavirus Disease 2019
por: Strauss, Ronald, et al.
Publicado: (2021)

Effects of nonpharmaceutical interventions for coronavirus disease 2019
por: Choi, Jae Hong
Publicado: (2022)

Effects of early corticosteroid use in patients with severe coronavirus disease 2019
por: Hyun, Jong Hoon, et al.
Publicado: (2021)

Coronavirus Disease 2019 and Stroke
por: Kim, Jong S.
Publicado: (2020)

Challenges of coronavirus disease 2019
por: The Lancet Infectious Diseases
Publicado: (2020)

2019 ERS cough guideline: consensus and controversy
por: Chen, Ruchong, et al.
Publicado: (2020)

Coronavirus controversy
por: Hofer, Ursula
Publicado: (2013)

Regarding: “Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019”
por: McCullough, Peter A.
Publicado: (2021)

Corticosteroids Treatment of Patients with Coronavirus Disease 2019: A Propensity Score Matching Study
por: Liang, Meng-yuan, et al.
Publicado: (2021)

Controversies
Publicado: (1896)

Controversy
Publicado: (1856)

Controversies in testosterone supplementation therapy
por: Khera, Mohit
Publicado: (2015)

Arterial Thrombosis and Coronavirus Disease 2019
por: McBane, Robert D.
Publicado: (2021)

Engel in the Time of Coronavirus Disease 2019
por: Davidson, John H.
Publicado: (2021)

Coronavirus Disease 2019 (COVID-19)
por: Goldust, Mohamad
Publicado: (2022)

Corticosteroids as adjunctive therapy in the treatment of coronavirus disease 2019: A report of two cases and literature review
por: Kosaka, Makoto, et al.
Publicado: (2021)

Screening for prostate cancer: Controversy? What controversy?
por: Ablin, R.J., et al.
Publicado: (2009)

Use of Corticosteroids in Coronavirus Disease 2019 Pneumonia: A Systematic Review of the Literature
por: Veronese, Nicola, et al.
Publicado: (2020)

Effectiveness of corticosteroids to treat coronavirus disease 2019 symptoms: A meta-analysis
por: Zeng, Yiqian, et al.
Publicado: (2022)

Effectiveness of corticosteroids to treat coronavirus disease 2019 symptoms: A meta-analysis
por: Zeng, Yiqian, et al.
Publicado: (2022)

Flibanserin: Approval of a controversial drug for a controversial disorder
por: Sathyanarayana Rao, T. S., et al.
Publicado: (2015)

Use of inhaled corticosteroids in asthma and coronavirus disease 2019: Keep calm and carry on
por: Lipworth, Brian, et al.
Publicado: (2020)

Corticosteroids for Urological Cancer Care During Coronavirus Disease 2019. Treat or Not to Treat?
por: Waterhouse, Jasmin V., et al.
Publicado: (2020)

Impact of Corticosteroids in Coronavirus Disease 2019 Outcomes: Systematic Review and Meta-analysis
por: Cano, Edison J., et al.
Publicado: (2021)

Sustained coronavirus disease 2019-related organizing pneumonia successfully treated with corticosteroid
por: Takumida, Hiroshi, et al.
Publicado: (2021)

Eosinophilic inflammation, coronavirus disease 2019, and asthma: Are inhaled corticosteroids the missing link?
por: Ramakrishnan, Sanjay, et al.
Publicado: (2021)

Resolution of Eosinophilic Pneumonia after Coronavirus Disease 2019 without Systemic Corticosteroids
por: Misaki, Yumiko, et al.
Publicado: (2023)

Social stigma in the time of coronavirus disease 2019
por: Sotgiu, Giovanni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_stroe52op9npe3loigqnqm0p1i